van der Schoot LS, Atalay S, Otero ME, Kievit W, et al. Regaining adequate treatment responses in patients with psoriasis who
discontinued dose reduction of adalimumab, etanercept or ustekinumab. Br J Dermatol 2022 Jul 27. doi: 10.1111/bjd.21797.
PMID: 35895852